Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
about
Belinostat in patients with refractory or relapsed peripheral T-cell lymphoma: a perspective reviewBendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyTreatment with a selenium-platinum compound induced T-cell acute lymphoblastic leukemia/lymphoma cells apoptosis through the mitochondrial signaling pathway.
P2860
Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Treatment response and overall ...... diffuse large B-cell lymphoma.
@en
Treatment response and overall ...... diffuse large B-cell lymphoma.
@nl
type
label
Treatment response and overall ...... diffuse large B-cell lymphoma.
@en
Treatment response and overall ...... diffuse large B-cell lymphoma.
@nl
prefLabel
Treatment response and overall ...... diffuse large B-cell lymphoma.
@en
Treatment response and overall ...... diffuse large B-cell lymphoma.
@nl
P2093
P2860
P1433
P1476
Treatment response and overall ...... diffuse large B-cell lymphoma.
@en
P2093
Armand Keating
John Kuruvilla
Khalil al-Farsi
Michael Crump
Noemi Puig
Tara Seshadri
P2860
P304
P356
10.3109/10428194.2012.719615
P577
2012-09-08T00:00:00Z